EZlifeBio
Latest round
- Series A
Last raised
- Apr 2017
Total raised
- $9.9M
Investors
- 2
About EZlifeBio
Established in 2015 and based in Guangzhou, China, EZlifeBio is a developer of tumor liquid biopsy technology, providing testing services such as early diagnosis of clinical tumors, efficacy monitoring. The company provides services such as early diagnosis of clinical tumors, efficacy monitoring, and targeted drug resistance detection. The company generates revenue by providing testing services for clinical tumor diagnosis, efficacy monitoring and targeted drug resistance detection.
Who invested in EZlifeBio
2 investors across 1 round
See all investors in EZlifeBio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Apr 12, 2017
Amount
$9.9M
Investors
Questions about EZlifeBio
Who invested in EZlifeBio?
EZlifeBio has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has EZlifeBio raised?
EZlifeBio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did EZlifeBio last raise money?
EZlifeBio's most recent round on record is a Series A, in Apr 2017.
What does EZlifeBio do?
Established in 2015 and based in Guangzhou, China, EZlifeBio is a developer of tumor liquid biopsy technology, providing testing services such as early diagnosis of clinical tumors, efficacy monitoring.
Where is EZlifeBio headquartered?
EZlifeBio is headquartered in Guangzhou, China.
Which VCs invest in companies like EZlifeBio?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at EZlifeBio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like EZlifeBio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.